Valuation: Clever Culture Systems Limited

Market Cap 39.28M 27.3M 24.26M 22.64M 20.64M 38.92M 2.62B 274M 106M 1.34B 103M 100M 4.31B P/E 2025
20x
P/E 2026 -21.1x
Enterprise Value 40.57M 28.19M 25.05M 23.38M 21.31M 40.19M 2.71B 283M 110M 1.39B 106M 104M 4.45B EV / Sales 2025
5.35x
EV / Sales 2026 11.1x
Free-Float
39.92%
Yield 2025 *
-
Yield 2026 -
1 day+2.78%
1 week+8.82%
Current month+2.78%
1 month+2.78%
3 months-15.91%
6 months-26.00%
Current year-36.21%
1 week 0.02
Extreme 0.016
0.02
1 month 0.02
Extreme 0.015
0.02
Current year 0.01
Extreme 0.013
0.03
1 year 0.01
Extreme 0.013
0.04
3 years 0
Extreme 0.004
0.04
5 years 0
Extreme 0.004
0.13
10 years 0
Extreme 0.004
1.08
Manager TitleAgeSince
Chief Executive Officer - 2016-08-07
Director of Finance/CFO - 2017-08-24
Chief Tech/Sci/R&D Officer - 2017-01-31
Director TitleAgeSince
Director/Board Member - 2016-08-07
Chairman - 2023-06-30
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%+8.82%-45.59%+42.31% 27.3M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+20.19%+79.01% 57.39B
+0.89%-0.63%+2.17%+35.99% 47.64B
+0.36%+0.81%+342.39%+748.97% 44.29B
-0.96%-4.50%+24.96%+31.45% 42.5B
-0.20%-0.77%+4.13%+111.69% 40.71B
-0.54%+2.93%+9.31%+54.06% 30.97B
+1.28%+3.28%+31.31%+28.55% 28.53B
+0.05%-1.64%-8.14%-12.10% 24.34B
Average +0.45%+0.06%+43.01%+121.41% 39.06B
Weighted average by Cap. +0.40%-0.84%+57.10%+139.50%

Financials

2025 2026
Net sales 5.46M 3.8M 3.37M 3.15M 2.87M 5.41M 365M 38.09M 14.76M 187M 14.25M 13.94M 599M 4.62M 3.21M 2.85M 2.66M 2.43M 4.58M 309M 32.22M 12.48M 158M 12.05M 11.79M 506M
Net income 1.68M 1.17M 1.04M 971K 885K 1.67M 113M 11.75M 4.55M 57.52M 4.39M 4.3M 185M -2.24M -1.56M -1.38M -1.29M -1.18M -2.22M -150M -15.61M -6.05M -76.44M -5.84M -5.71M -245M
Net Debt 950K 660K 587K 548K 499K 941K 63.47M 6.63M 2.57M 32.45M 2.48M 2.43M 104M 1.29M 894K 794K 741K 676K 1.27M 85.92M 8.97M 3.48M 43.93M 3.36M 3.28M 141M
Logo Clever Culture Systems Limited
Clever Culture Systems Limited is an Australia-based company, which provides intelligent automation solutions to microbiology laboratories. It has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence and machine learning software to automate the imaging, analysis and interpretation of microbiology culture plates. The technology United States FDA-cleared artificial intelligence technology for automated culture plate reading. The product is being sold to microbiology laboratories in the pharmaceutical manufacturing sector for the reading of environmental monitoring culture plates and to clinical laboratories as an in vitro diagnostic for infectious diseases. Thermo Fisher Scientific, Inc is distributor of the APAS Independence to clinical customers in the United States and selected countries in Europe. It offers a range of APAS Independence Analysis Modules that are validated across multiple culture plate media and sample types.
Employees
19
Date Price Change Volume
26-10-04 A$0.0185 +2.78% 26,144
26-10-02 A$0.0180 0.00% 250,088
26-10-01 A$0.0180 0.00% 200,000
26-09-30 A$0.0180 0.00% 2,024,013
26-09-29 A$0.0180 +5.88% 869,438